Closure of Trading Window
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd has informed BSE that its trading window for dealing in company securities will be closed from 1st October 2025 until 48 hours after the declaration of unaudited financial results for the quarter and half-year ending 30th September 2025. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 (amended 2018) and applies to all designated persons and their immediate relatives, who are barred from trading in the company's shares during this period. The company has also stated that the date of the board meeting to consider these Q2/H1 FY26 results will be communicated separately. The letter was signed by D. Bhagat Reddy, Managing Director, on 24th September 2025.
This is a routine regulatory compliance announcement and not material to the stock price in itself. However, it signals that Q2 and H1 FY26 financial results are due shortly, which may drive stock movement once the numbers are announced.